Barbara Kranner
Impact in
- Pharmacology top 5%
- Cannabis and Cannabinoid Research
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Neuroscience and Neuropharmacology Research 6
- Nerve injury and regeneration 2
-
- Cannabis and Cannabinoid Research 5
- Co-authors
- Rudolf Moldzio (15 shared papers)Wolf‐Dieter Rausch (9 shared papers)Christopher Krewenka (14 shared papers)Khaled Radad (11 shared papers)Mubarak Al‐Shraim (3 shared papers)J. Catharina Duvigneau (7 shared papers)Chi Huu Nguyen (3 shared papers)Feixue Wang (1 shared paper)
- Journals
- Journal of Neural Transmission (3 papers)Planta Medica (2 papers)Neurotoxicology and Teratology (1 paper)Phytomedicine (1 paper)CNS & Neurological Disorders - Drug Targets (1 paper)
- Partner nations
- AustriaEgyptSaudi Arabia
In The Last Decade
Barbara Kranner
15 papers receiving 394 citations
Peers
Comparison fields: 5 of 71
- Pharmacology 163
- Geriatrics and Gerontology 23
- Cellular and Molecular Neuroscience 130
- Biological Psychiatry 16
- Neurology 83
Countries citing papers authored by Barbara Kranner
This map shows the geographic impact of Barbara Kranner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Kranner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Kranner more than expected).
Fields of papers citing papers by Barbara Kranner
This network shows the impact of papers produced by Barbara Kranner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Kranner. The network helps show where Barbara Kranner may publish in the future.
Co-authors
The 19 scholars most cited alongside Barbara Kranner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 104 | |
| 2 | 2019 | 95 | |
| 3 | 2012 | 54 | |
| 4 | 2023 | 26 | |
| 5 | 2017 | 23 | |
| 6 | 2015 | 21 | |
| 7 | 2009 | 19 | |
| 8 | 2013 | 19 | |
| 9 | 2016 | 14 | |
| 10 | 2006 | 14 | |
| 11 | 2021 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2011 | 3 | |
| 14 | 2021 | 2 | |
| 15 | 2012 | 1 |
About Barbara Kranner
Barbara Kranner is a scholar working on Cellular and Molecular Neuroscience, Pharmacology, Neurology, Plant Science and Complementary and alternative medicine, having authored 15 papers that have together received 402 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (6 papers), Cannabis and Cannabinoid Research (5 papers), GABA and Rice Research (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Nerve injury and regeneration (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), Phytochemicals and Antioxidant Activities (1 paper) and Chemotherapy-induced organ toxicity mitigation (1 paper). The work is most often cited by research in Pharmacology (163 citations), Geriatrics and Gerontology (23 citations), Cellular and Molecular Neuroscience (130 citations), Biological Psychiatry (16 citations) and Neurology (83 citations). Barbara Kranner has collaborated with scholars based in Austria, Egypt and Saudi Arabia. Frequent co-authors include Rudolf Moldzio, Wolf‐Dieter Rausch, Christopher Krewenka, Khaled Radad, Mubarak Al‐Shraim, J. Catharina Duvigneau, Chi Huu Nguyen, Feixue Wang, Ahmed Al‐Emam and Thomas Pacher. Their work appears in journals such as Journal of Neural Transmission, Planta Medica, Neurotoxicology and Teratology, Phytomedicine and CNS & Neurological Disorders - Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.